Insulin-like growth factor-I and bone: lessons from mice and men

被引：41

作者：

Kawai, Masanobu ^{[1
]}

Rosen, Clifford J. ^{[1
]}

机构：

[1] Maine Med Ctr, Res Inst, Scarborough, ME 04074 USA

来源：

PEDIATRIC NEPHROLOGY | 2009年 / 24卷 / 07期

关键词：

Insulin-like growth factor-I; Skeletal acquisition; QUANTITATIVE TRAIT LOCI; GENE PROMOTER POLYMORPHISM; MINERAL DENSITY; POSTNATAL-GROWTH; TRANSGENIC MICE; OSTEOBLAST DIFFERENTIATION; OSTEOPOROTIC PATIENTS; BODY-COMPOSITION; ADULT PATIENTS; PPAR-GAMMA;

D O I：

10.1007/s00467-008-1040-6

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Studies of humans and animals have illustrated a strong association between insulin-like growth factor (IGF)-I and skeletal acquisition. However, the precise molecular and cellular mechanisms underlying this effect still largely remain unknown. Recent advances in molecular and genetic techniques for in vivo studies provide excellent tools for us to explore how circulating and skeletal insulin-like growth factor-I (IGF-I) may affect not only peak bone mass but also bone loss. This review highlights recent findings that shed new light on the interaction of the IGF-I signaling pathway with other skeletal networks, and the role of IGF-I in the bone marrow milieu.

引用

页码：1277 / 1285

页数：9

共 71 条

[51] Mechanisms of disease: is osteoporosis the obesity of bone? [J].

Rosen, CJ ;

Bouxsein, ML .

NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2006, 2 (01) :35-43

[52] Congenic mice with low serum lGF-I have increased body fat, reduced bone mineral density, and an altered osteoblast differentiation program [J].

Rosen, CJ ;

Ackert-Bicknell, CL ;

Adamo, ML ;

Shultz, KL ;

Rubin, J ;

Donahue, LR ;

Horton, LG ;

Delahunty, KM ;

Beamer, WG ;

Sipos, J ;

Clemmons, D ;

Nelson, T ;

Bouxsein, ML ;

Horowitz, M .

BONE, 2004, 35 (05) :1046-1058

[53]

ROSEN CJ, 1994, P SOC EXP BIOL MED, V206, P83

[54]

Rosen CJ, 2008, PRINCIPLES OF BONE BIOLOGY, VOL 2, 3RD EDITION, P1069, DOI 10.1016/B978-0-12-373884-4.00017-3

[55] Adipocyte differentiation from the inside out [J].

Rosen, Evan D. ;

MacDougald, Ormond A. .

NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2006, 7 (12) :885-896

[56] REDUCED BONE-MINERAL CONTENT IN ADULT PATIENTS WITH GROWTH-HORMONE DEFICIENCY [J].

ROSEN, T ;

HANSSON, T ;

GRANHED, H ;

SZUCS, J ;

BENGTSSON, BA .

ACTA ENDOCRINOLOGICA, 1993, 129 (03) :201-206

[57] Bone is a target for the antidiabetic compound rosiglitazone [J].

Rzonca, SO ;

Suva, LJ ;

Gaddy, D ;

Montague, DC ;

Lecka-Czernik, B .

ENDOCRINOLOGY, 2004, 145 (01) :401-406

[58] EFFECTS OF LONG-TERM TREATMENT WITH GROWTH-HORMONE ON BONE AND MINERAL METABOLISM IN CHILDREN WITH GROWTH-HORMONE DEFICIENCY [J].

SAGGESE, G ;

BARONCELLI, GI ;

BERTELLONI, S ;

CINQUANTA, L ;

DINERO, G .

JOURNAL OF PEDIATRICS, 1993, 122 (01) :37-45

[59]

SALMON WD, 1957, J LAB CLIN MED, V49, P825

[60] 1,25-DIHYDROXYVITAMIN D-3 INCREASES SECRETION OF INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-4 (IGFBP-4) BY HUMAN OSTEOBLAST-LIKE CELLS IN-VITRO AND ELEVATES IGFBP-4 SERUM LEVELS IN-VIVO [J].

SCHARLA, SH ;

STRONG, DD ;

ROSEN, C ;

MOHAN, S ;

HOLICK, M ;

BAYLINK, DJ ;

LINKHART, TA .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (05) :1190-1197

← 1 2 3 4 5 6 7 8 →